|
|
Biggest News in Hair Loss Treatment
since Rogaine® & Propecia®

Lasercomb: FDA Clearance !
clinically proven to promote hair growth
No Drugs, No Surgery, No Side Effects
February 2007 -
Lexington International LLC is proud to
announce the landmark achievement of
US Food & Drug Administration (FDA)
clearance for their medical laser device, the HairMax LaserComb®.
Through years of extensive research and clinical studies in the
science of hair growth, Lexington has developed an affordable and
convenient, hand-held laser device, now clinically proven to promote
hair growth in males with androgenetic alopecia (Norwood IIA to V with
Fitzpatrick skin types I to IV).
To view FDA’s public record of this clearance visit
www.fda.gov/cdrh/pdf6/K060305.pdf
This FDA clearance of the HairMax LaserComb offers an exciting new
modality for the promotion of hair growth in males. Until now, the FDA
has only approved two other products as solutions to combat hair loss,
a condition that affects approximately 55 million men in the U.S. But
the HairMax LaserComb stands out as the only proven drug-free
alternative. This gives many hair loss sufferers, previously unable or
unwilling to turn to drug-based solutions, newfound hope in their
battle. Fortunately, treatments using the HairMax LaserComb are easy
to administer, only 10 to 15 minutes three times per week, and the
laser device is convenient to use in the comfort and privacy of your
own home.
For the FDA submission, Lexington conducted an extensive clinical
study in four different locations across the United States. The study
concluded that 93% of the participants (ages 30-60) using the HairMax
LaserComb had an increase in the number of terminal (thick) hairs. The
average number of terminal hairs per square centimeter increased by 19
hairs/cm² over a six-month period. During the study, there were no
reports of serious adverse events. The number and types of adverse
events were similar in both the active and placebo groups.
Lexington’s clinical study investigating the efficacy of the HairMax
LaserComb in females is concluding and they will be submitting the
data to the FDA shortly.
David Michaels, Managing Director, shares his thoughts on this
momentous announcement, “We are very excited that we have reached a
major milestone in hair care and science. Laser hair therapy is the
talk of the hair restoration industry today. And not only were the
results of this study extremely significant, but with the credibility
of the FDA clearance, we are soundly positioned to make a substantial
impact in the emerging hair restoration industry.”
Dr. Matt Leavitt, Chief Medical Advisor
to Lexington, expresses his enthusiasm on news of the FDA clearance,
“The HairMax LaserComb is a method of treatment that can be of great
help to men of all ages suffering from hair loss. I am impressed with
the protocol and results from the clinical trials that Lexington has
conducted. With the FDA clearing the HairMax LaserComb as a medical
device, it offers an attractive option for hair growth for medical
practitioners. We can now deliver a new modality to our patients and
achieve strong user satisfaction.”
Randy Veliky, Lexington COO, concludes, “The HairMax LaserComb will
revolutionize the hair growth industry, but we are not stopping there.
Lexington is dedicated to continuing research into laser technology. We
will be expanding our offering of laser hair growth solutions to include
freestanding clinical units, affordable laser panel arrays for the home
market and broadening the features of our current products.”
For over 20 years, the directors of Lexington have been at the forefront
of laser hair growth research. Born from this passion for innovation,
The HairMax LaserComb uses a patented technology to part the hair
allowing the focused laser energy to reach the scalp. The laser is most
effective when it has an unobstructed path directly to the hair
follicle. Through extensive research, Lexington has determined the
optimal wavelength and energy level needed to deliver maximum results.
Lexington’s continued dedication to consistent innovation ensures that
users are always receiving the latest in laser hair technology.
About Lexington International, LLC
Originating in Sydney Australia and now based in Boca Raton Florida,
Lexington manufactures and distributes the HairMax LaserComb® (www.hairmax.com)
to more than 80 countries and has provided new hope and satisfaction to
tens of thousands of customers since 2001. The HairMax LaserComb is
based on 20 years of international research and studies on the effects
of Low Level Laser use. Both the press and users alike have universally
taken to the HairMax LaserComb. Coverage has included Dateline NBC, TIME
Magazine, as one of their “Inventions of the Year”, as well as the
November 2004 issue of Good Housekeeping Magazine.
Lexington is an ISO 9001 & 13485 Quality Assured laser manufacturer. We
follow GMP (Good Manufacturing Practices) of a medical device
manufacturer. Clinical studies closely adhered to GCP (Good Clinical
Practices) with a protocols and case report forms reviewed by an IRB
(Ethics Committee). Lexington is also a member in good standing of the
Better Business Bureau.
Lexington is a proud participant of “Team Florida” and has participated
in high-level, overseas trade missions with Governor Jeb Bush.
Additionally, the company was awarded by the U.S. Department of Commerce
for “Commercial and Export Achievement”.
reprint with permission of Lexington International LLC
Lasercomb's clinical study - click here
Lasercomb FDA Clinic Study - click here
BEFORE & AFTER
PHOTOS
Dr.
Martin Unger - Patient Chart
Subject:
Patient CS - 46 year old male.
|
|
Magnification: x50 |
|
Picture A
|
|
Picture B
|
|

|
|
|
Date: March 27 |
Date: July 9th same year |
Dr.
Martin Unger - Patient Chart
Subject:
Patient LA - 49 year old male.
|
|
Magnification: x50 |
|
Picture A
|
|
Picture B
|
|

|
|
|
Date: January
25 |
Date: April 17 same year |
|
click here for more patients results
If you
have questions, email hairsite@aol.com
|
Questions about the Lasercomb?
Enter your information
below and we will respond within
48 hours by email. All questions will be answered. |
|
|
|
|